FDA Adverse Event Malfunction Summary report: N

ALERE DETERMINE HIV 1/2 AG/AB COMBO

MDR report key: 7345360 · Received March 16, 2018

Report

Report Number
1221359-2018-00006
Event Type
Malfunction
Date Received
March 16, 2018
Date of Event
December 30, 2017
Report Date
March 16, 2018
Manufacturer
ALERE SCARBOROUGH INC.
Product Code
MZF
UDI-DI
10811877010293
PMA / PMN Number
BP120037-0
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

TESTING WAS PERFORMED BY ALERE (B)(4) ON RETAINED KIT LOT# 091493. THE RETENTION LOT TESTING YIELDED EXPECTED RESULTS WHEN TESTING INTERNAL QC SAMPLES. THE MANUFACTURING BATCH RECORD REVIEW FOR LOT 091493 DID NOT REVEAL ANY FAILURES OF ACCEPTANCE CRITERIA. THIS LOT MET THE REQUIRED RELEASE SPECIFICATIONS. ALERE (B)(4) WAS UNABLE TO DETERMINE THE EXACT ROOT CAUSE OF THE REPORTED ISSUE. THE RESULTS OBTAINED MAY POSSIBLY BE RELATED TO THE PATIENT SAMPLE. THE SAMPLE MAY HAVE CONTAINED SPECIFIC SUBSTANCES WHICH MAY HAVE AFFECTED THE RESULTS. A REVIEW OF THE COMPLAINTS REPORTING FALSE POSITIVE OR UNCONFIRMED FALSE POSITIVE RELATED TO LOT NUMBER 091493 SHOWED THAT THE COMPLAINT RATE IS (B)(4). THE EVIDENCE AVAILABLE SUGGESTS THAT THIS DEVICE LOT IS PERFORMING WITHIN LABELED CLAIMS. NOTE: THIS MDR IS A RETROSPECTIVE FILING IN RESPONSE TO AN OBSERVATION FROM AN FDA INSPECTION CONDUCTED FEBRUARY 26TH - MARCH 2ND AT ALERE (B)(4).

Description of Event or Problem · 1

THE CUSTOMER REPORTED A (B)(6) RESULT WAS OBTAINED WITH THE ALERE DETERMINE HIV ½ AG/AB COMBO TEST ON A LABOR AND DELIVERY PATIENT. THE PATIENT WAS CONFIRMED (B)(6) BY ABBOTT ARCHITECH. IT IS UNKNOWN WHAT WEEK OF PREGNANCY THE PATIENT WAS IN AT THE TIME OF THE TESTING OR IF/WHEN THE PATIENT DELIVERED. NO ADVERSE OUTCOME WAS REPORTED BY THE CUSTOMER.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
189911 ALERE DETERMINE HIV 1/2 AG/AB COMBO IVD FOR HIV AG/AB MZF ALERE SCARBOROUGH INC. 091493 10811877010293

Patients

Seq Age Sex Outcome Treatment
1